Font Size
A
A
A

Prostate Cancer (cont.)

Related Information

References

Citations

  1. American Cancer Society (2009). Cancer Facts and Figures 2009. Atlanta: American Cancer Society. Available online: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf.pdf.

  2. Zelefsky MJ, et al. (2008). Cancer of the prostate. In VT DeVita Jr et al., eds., Devita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology, 8th ed., vol. 1, pp. 1392–1452. Philadelphia: Lippincott Williams and Wilkins.

  3. U.S. Preventive Services Task Force (2008). Screening for Prostate Cancer: Clinical Summary of a U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.ahrq.gov/clinic/uspstf08/prostate/prostaters.htm.

  4. Robbins C, et al. (2007). Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Research, 17(12): 1717–1722.

  5. Kantoff PW (2007). Prostate cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 9. New York: WebMD.

  6. National Comprehensive Cancer Network (2009). Prostate cancer. NCCN Clinical Practice Guidelines in Oncology, version 2.2009. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.

  7. D'Amico AV, et al. (2007). Radiation therapy for prostate cancer. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 3006–3031. Philadelphia: Saunders Elsevier.

  8. Agency for Healthcare Research and Quality (2008). Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: Executive Summary (AHRQ Pub. No. 08-EHC010-1). Rockville, MD: Agency for Healthcare Research and Quality. Available online: http://www.effectivehealthcare.ahrq.gov/ehc/products/9/79/2008_0204prostatecancerexecsum.pdf.

Other Works Consulted

  • Ahmed HU, et al. (2007). Will focal therapy become a standard of care for men with localized prostate cancer? Nature Clinical Practice Oncology, 4(11): 632–642.

  • American Cancer Society (2009). Cancer Facts and Figures 2009. Atlanta: American Cancer Society. Available online: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf.pdf.

  • Chen RC, et al. (2008). Treatment "mismatch" in early prostate cancer: Do treatment choices take patient quality of life into account? Cancer, 112(1): 61–68.

  • D’Amico, et al. (2008). Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial. JAMA, 299(3): 289–295.

  • Elkord E (2007). Immunology and immunotherapy approaches for prostate cancer. Prostate Cancer Prostatic Disease, 10(3): 224–236.

  • Hartke DM, Resnick MI (2007). Radical perineal prostatectomy. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2979–2984. Philadelphia: Saunders Elsevier.

  • Keating NL, et al. (2010). Diabetes and cardiovascular disease during androgen deprivation therapy: Observational study of veterans with prostate cancer. Journal of the National Cancer Institute, 102(1): 39–46.

  • Malcolm JB, et al. (2010). Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. Journal of Urology, 183(5): 1822–1828.

  • National Cancer Institute (2010). Prostate Cancer PDQ: Treatment – Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/patient.

  • National Comprehensive Cancer Network (2009). Prostate cancer. NCCN Clinical Practice Guidelines in Oncology, version 2.2009. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.

  • Pagana KD, Pagana TJ (2010). Mosby’s Manual of Diagnostic and Laboratory Tests, 4th ed. St. Louis: Mosby Elsevier.

  • Redman MW, et al. (2008). Finasteride does not increase the risk of high-grade prostate cancer: A bias-adjusted modeling approach. Cancer Prevention Research. Published online May 18, 2008 (doi:10.1158/1940-6207.CAPR-08-0092).

  • Su L, Smith JA (2007). Laparoscopic and robotic-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy. In AJ Wein et al., eds. Campbell-Walsh Urology, 9th ed., vol. 3, pp. 2985–3005. Philadelphia: Saunders Elsevier.

  • Tunn U (2007). The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: Putting IAD under the spotlight. British Journal of Urology International, 99(Suppl 1): 19–24.

Next Page:

eMedicineHealth Medical Reference from Healthwise

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

To learn more visit Healthwise.org

© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.






Medical Dictionary